Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer
Elena Peruzzi, Lorenzo Gerratana, Marcella Montico, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115479-115479
Open Access | Times Cited: 9

Showing 9 citing articles:

Abemaciclib pharmacology and interactions in the treatment of HR+/HER2− breast cancer: a critical review
Federica Martorana, Maria Vita Sanò, Maria Rosaria Valerio, et al.
Therapeutic Advances in Drug Safety (2024) Vol. 15
Open Access | Times Cited: 7
Physiologically Based Pharmacokinetic Model of Plasma and Intracranial Pharmacokinetics and CDK4/6 Occupancy of Abemaciclib to Optimizing Dosing Regimen for Brain Metastatic Patients
Chao Zhang, Shan Li, Jiawei Ren, et al.
ACS Omega (2025) Vol. 10, Iss. 9, pp. 9245-9256
Open Access
Optimizing Zanubrutinib Dosing in Patients: A PBPK‐BO Model Approach to Drug–Drug Interactions and Patients with Hepatic Impairment
Jiawei Ren, Dan Shan, Guijuan Yue, et al.
The Journal of Clinical Pharmacology (2025)
Closed Access
Drug-Drug interactions and special considerations in breast cancer patients treated with CDK4/6 inhibitors: A comprehensive review
Taha Koray Şahin, Gözde Kavgacı, Deniz Can Güven, et al.
Cancer Treatment Reviews (2025), pp. 102956-102956
Closed Access
Exploring pharmacokinetic variability of palbociclib in HR+/HER2- metastatic breast cancer: a focus on age, renal function, and drug–gene interactions
Elena Peruzzi, Bianca Posocco, Lorenzo Gerratana, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Adverse event profiles of CDK4/6 inhibitors: data mining and disproportionality analysis of the FDA adverse event reporting system
Jun Shen, Pingli Luo, Jianmei Xu
Therapeutic Advances in Drug Safety (2024) Vol. 15
Open Access | Times Cited: 2
Potential association of SULT2A1 and ABCG2 variant alleles with increased risk for palbociclib toxicity
Chong Wang, Mary Hwang, Brandon Paulson, et al.
Pharmacogenomics (2024) Vol. 25, Iss. 8-9, pp. 367-375
Closed Access | Times Cited: 1
An accurate haplotyping method using multiplex pyrosequencing with AS-PCR to detect ABCB1 haplotypes associated with rivaroxaban-derived hemorrhagic events
Shanshan Wang, Liteng Wang, Meng Wei, et al.
Talanta (2024) Vol. 281, pp. 126861-126861
Closed Access
Research on Genetic Variant Characteristics in ADME Genes Based on Whole-Exome Sequencing in the Han Chinese Population
Ling Ye, Xiangguang Meng, Yan Zhan, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 205, pp. 106987-106987
Open Access
Page 1

Scroll to top